Search
Mineralys Therapeutics Inc
MLYSAdd to Watchlist
26.890USD
-0.090-0.33%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
2.19BMarket Cap
LossP/E TTM
Mineralys Therapeutics Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-2.29
37.60%
Analyst Rating
BUY
2026-07-01
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of Mineralys Therapeutics Inc?
According to Mineralys Therapeutics Inc's FY2025 earnings report, its current assets were 661.39M, with a year-on-year change of 222.08.
What are the total assets of Mineralys Therapeutics Inc?
According to Mineralys Therapeutics Inc's FY2025 earnings report, its total assets of Mineralys Therapeutics Inc were 661.81M, with a year-on-year change of 221.42.
What are the total liabilities of Mineralys Therapeutics Inc?
According to Mineralys Therapeutics Inc's FY2025 earnings report, its total liabilities of Mineralys Therapeutics Inc were 15.11M, with a year-on-year change of 3.19.
What is the total equity of Mineralys Therapeutics Inc?
According to Mineralys Therapeutics Inc's FY2025 earnings report, its total equity of Mineralys Therapeutics Inc was 646.69M, with a year-on-year change of 238.13.
What is the net investment of Mineralys Therapeutics Inc?
According to Mineralys Therapeutics Inc's FY2025 earnings report, its net investment of Mineralys Therapeutics Inc was -389.75M, with a year-on-year change of -439.04.
What is the net financing of Mineralys Therapeutics Inc?
According to Mineralys Therapeutics Inc's FY2025 earnings report, its net financing of Mineralys Therapeutics Inc was 591.00M, with a year-on-year change of 408.86.
What is the Earnings Per Share (EPS) of Mineralys Therapeutics Inc?
According to Mineralys Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.29, with a year-on-year change of 37.60.
What is the Return on Equity (ROE) of Mineralys Therapeutics Inc?
According to Mineralys Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -36.91, with a year-on-year change of 55.12.
What is the Return on Assets (ROA) of Mineralys Therapeutics Inc?
According to Mineralys Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -35.65, with a year-on-year change of 54.14.
What is the operating profit of Mineralys Therapeutics Inc?
According to Mineralys Therapeutics Inc's FY2025 earnings report, its operating profit was -170.60M, with a year-on-year change of 11.33.